Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This study will compare bifeprunox to a currently marketed medication, Zyprexa (olanzapine),
with respect to the affect on weight during the treatment of outpatients with schizophrenia.
The study will compare the effect of these medications on several variables, including body
weight and triglyceride levels.